课题基金 / 基金详情

SMAD MEDIATED SIGNALING DURING LUNG MORPHOGENESIS

SMAD MEDIATED SIGNALING DURING LUNG MORPHOGENESIS
肺形态发生过程中 SMAD 介导的信号传导
批准号:
6390086
负责人:
WEI SHI
金额:
$25.05万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-08-01 至 2003-07-31

项目摘要

项目成果

WEI SHI的其他基金

相似基金

相关文献

中文摘要
翻译
对肺的分子胚胎学的研究可能对肺发育、损伤和疾病的分子机制提供重要的新的理解。我们已经证明了转化生长因子-β受体介导的自分泌/旁分泌信号负向调节早期肺发育。最近对Smad家族信号转导蛋白的发现揭示了转化生长因子-β信号从细胞膜到细胞核的新机制,我们的初步数据表明,Smad介导的信号调节小鼠肺分支的形态发生和细胞分化。假设:特定的Smad基因表达调节转化生长因子-β信号,从而指导早期小鼠胚胎肺分支的形态发生。目的:1.明确Smad基因在胚胎肺发育过程中的发育和时空表达(I)体内和(II)肺外植体培养。目的:采用(I)“功能丧失”和(Ii)“功能获得”策略,研究转化生长因子-β途径限制性的Smad2和Smad3在无血清培养中调节胚胎肺分支形态发生和细胞分化的分子机制。目的3.明确反馈抑制蛋白Smad6和Smad7在胚胎肺分支形态发生过程中的生物学功能。(I)肺组织培养中,Smad6和Smad7基因的表达模式将被描述为时间和剂量依赖的转化生长因子-β诱导的抑制性Smad6和Smad7基因的表达模式。(Ii)抑制Smad6和Smad7在肺发育过程中对转化生长因子-β信号转导的拮抗机制将在胚胎肺培养中确定。控制肺形态发生的新分子机制及其对人类健康的意义:目前的提议将定义Smad介导的信号调节胚胎肺分支形态发生的新分子机制。该项目的结果将为新的治疗策略提供新的理论基础,以调节肺发育、损伤、修复和疾病过程中的转化生长因子-β信号。
英文摘要
Studies of the molecular embryology of the lung are likely to provide significant new understanding of the molecular mechanisms of lung development, injury and disease. We have demonstrated that TGF-beta receptor-mediated autocrine/paracrine signaling negatively regulates early lung development. The recent identification of the Smad family signal transducer proteins has unraveled new mechanisms by which TGF-beta signals from the cell membrane to the nucleus, and our preliminary data show that Smad-mediated signaling modulates mouse lung branching morphogenesis and cytodifferentiation. Hypothesis: Specific Smad gene expression regulates TGF-beta signaling, and thus instructs early mouse embryonic lung branching morphogenesis. Specific Aims: Aim 1. To define the developmental and temporo-spatial expression of Smad genes during embryonic lung development (i) in vivo and (ii) in lung explant culture. Aim 2. To determine the molecular mechanism of TGF-beta pathway- restricted Smad2 and Smad3 in regulating embryonic pulmonary branching morphogenesis and cytodifferentiation in serumless culture using both (i) "loss-of-function" and (ii) "gain-of- function" strategies. Aim 3. To define the biological function of the feedback inhibitory Smad6 and Smad7 proteins during embryonic lung branching morphogenesis in culture. (i) Time- and dose-dependent TGF-beta-induced inhibitory Smad6 and Smad7 gene expression patterns will be delineated in lung explant culture. (ii) The antagonistic mechanism by inhibitory Smad6 and Smad7 on TGF-beta signaling during lung development will be determined in embryonic lung culture. Novel molecular mechanisms to control lung morphogenesis and significance to human health: The current proposal will define novel molecular mechanisms in which Smad-mediated signaling regulates embryonic lung branching morphogenesis. The results of this project will provide new rationales for novel therapeutic strategies to modulate TGF-beta signaling during lung development, injury, repair, and disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathogenic Mechanisms of Pulmonary Lymphangioleiomyomatosis
  • 批准号:
    10768216
  • 项目类别:
  • 资助金额:
    $30.61万
  • 财政年份:
    2023
  • 负责人:
    WEI SHI
  • 依托单位:
Lung Development and Diseases
Lung Development and Diseases
  • 批准号:
    10573209
  • 项目类别:
  • 资助金额:
    $49.55万
  • 财政年份:
    2022
  • 负责人:
    WEI SHI
  • 依托单位:
Molecular mechanisms of pulmonary disease in Birt-Hogg-Dube syndrome
  • 批准号:
    10805544
  • 项目类别:
  • 资助金额:
    $12.75万
  • 财政年份:
    2018
  • 负责人:
    WEI SHI
  • 依托单位:
海外基金